The RUNX1 Research Program (runx1.com) is the only nonprofit organization committed to finding a cure for RUNX1 FPD/AML, a hereditary blood disorder that predisposes to leukemia.  Its primary purpose is to fund cutting-edge leukemia research, and in the last 12 months it has funded nine grants totaling approximately $3.5mm.  As well as bringing attention and visibility to the disorder and the RUNX1 mutation, the organization aims to support patients by providing a forum in which to help educate and connect them with others.  Although considered an orphan disease, RUNX1 FPD/AML research findings are useful to the larger leukemia field as well as to the expanding realm of inherited cancers.  The RUNX1 Research Program was founded in 2016 by The Babich Family Foundation in Santa Barbara and will be headquartered in Palo Alto.